Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
910 Ergebnisse
| GW02Y8 | Regeneron Pharmaceuticals Inc./OS/Call [820]/GOLDS | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,521 % | 0,319 | -0,011 | 5,784 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW05ZY | Regeneron Pharmaceuticals Inc./OS/Call [820]/GOLDS | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,629 % | 0,463 | -0,009 | 3,442 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1J0K | Regeneron Pharmaceuticals Inc./OS/Call [820]/GOLDS | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,428 % | 0,451 | -0,009 | 3,582 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K44 | Regeneron Pharmaceuticals Inc./OS/Call [820]/GOLDS | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,140 % | 0,425 | -0,010 | 3,909 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K5A | Regeneron Pharmaceuticals Inc./OS/Call [820]/GOLDS | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,428 % | 0,451 | -0,009 | 3,582 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K5H | Regeneron Pharmaceuticals Inc./OS/Call [820]/GOLDS | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,629 % | 0,463 | -0,009 | 3,442 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1K8S | Regeneron Pharmaceuticals Inc./OS/Call [820]/GOLDS | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,926 % | 0,382 | -0,010 | 4,609 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW3S4H | Regeneron Pharmaceuticals Inc./OS/Call [820]/GOLDS | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,784 % | 0,478 | -0,008 | 3,262 | 17.03.2028 | 0,010 | Goldman Sachs | ||
| GW4QF9 | Regeneron Pharmaceuticals Inc./OS/Call [820]/GOLDS | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,994 % | 0,501 | -0,008 | 3,023 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| JZ97V8 | Regeneron Pharmaceuticals Inc./OS/Call [820]/JPMD | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,397 % | 0,096 | -0,010 | 14,699 | 18.09.2026 | 0,010 | JP Morgan | ||
| JE1X3C | Regeneron Pharmaceuticals Inc./OS/Call [820]/JPMD | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,503 % | 0,319 | -0,011 | 5,786 | 19.03.2027 | 0,010 | JP Morgan | ||
| JY3SF2 | Regeneron Pharmaceuticals Inc./OS/Call [820]/JPMD | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 35,774 % | 0,249 | -0,010 | 7,618 | 15.01.2027 | 0,010 | JP Morgan | ||
| JY5TYY | Regeneron Pharmaceuticals Inc./OS/Call [820]/JPMD | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 35,711 % | 0,231 | -0,011 | 8,434 | 18.12.2026 | 0,010 | JP Morgan | ||
| MJ5C67 |  | Regeneron Pharmaceuticals Inc./OS/Call [825]/MS | - | - | 825,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,415 % | 0,235 | -0,011 | 7,680 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MM7L6N | | Regeneron Pharmaceuticals Inc./OS/Call [825]/MS | - | - | 825,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,249 % | 0,372 | -0,010 | 4,525 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MM7L6P | | Regeneron Pharmaceuticals Inc./OS/Call [825]/MS | - | - | 825,000 | call | Regeneron Pharmaceuticals Inc. | - | 46,113 % | 0,130 | -0,014 | 11,939 | 18.09.2026 | 0,010 | Morgan Stanley | |
| MN1HGS | | Regeneron Pharmaceuticals Inc./OS/Call [825]/MS | - | - | 825,000 | call | Regeneron Pharmaceuticals Inc. | - | 44,425 % | 0,469 | -0,009 | 3,282 | 17.12.2027 | 0,010 | Morgan Stanley | |
| MN6F49 | | Regeneron Pharmaceuticals Inc./OS/Call [825]/MS | - | - | 825,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,195 % | 0,316 | -0,011 | 5,472 | 19.03.2027 | 0,010 | Morgan Stanley | |
| MR4HMG | | Regeneron Pharmaceuticals Inc./OS/Call [825]/MS | - | - | 825,000 | call | Regeneron Pharmaceuticals Inc. | - | 49,284 % | 0,538 | -0,009 | 2,576 | 16.06.2028 | 0,010 | Morgan Stanley | |
| GW1J11 | Regeneron Pharmaceuticals Inc./OS/Call [830]/GOLDS | - | - | 830,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,524 % | 0,442 | -0,009 | 3,607 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K43 | Regeneron Pharmaceuticals Inc./OS/Call [830]/GOLDS | - | - | 830,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,149 % | 0,415 | -0,009 | 3,945 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K4Q | Regeneron Pharmaceuticals Inc./OS/Call [830]/GOLDS | - | - | 830,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,332 % | 0,452 | -0,008 | 3,496 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1K78 | Regeneron Pharmaceuticals Inc./OS/Call [830]/GOLDS | - | - | 830,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,528 % | 0,442 | -0,009 | 3,606 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K8L | Regeneron Pharmaceuticals Inc./OS/Call [830]/GOLDS | - | - | 830,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,926 % | 0,365 | -0,010 | 4,684 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW3S89 | Regeneron Pharmaceuticals Inc./OS/Call [830]/GOLDS | - | - | 830,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,547 % | 0,468 | -0,008 | 3,307 | 17.03.2028 | 0,010 | Goldman Sachs | ||
| GW4QF8 | Regeneron Pharmaceuticals Inc./OS/Call [830]/GOLDS | - | - | 830,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,702 % | 0,491 | -0,008 | 3,065 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| GW02RA | Regeneron Pharmaceuticals Inc./OS/Call [840]/GOLDS | - | - | 840,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,848 % | 0,402 | -0,009 | 4,017 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW02RF | Regeneron Pharmaceuticals Inc./OS/Call [840]/GOLDS | - | - | 840,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,740 % | 0,295 | -0,010 | 5,904 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW02RR | Regeneron Pharmaceuticals Inc./OS/Call [840]/GOLDS | - | - | 840,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,954 % | 0,358 | -0,010 | 4,715 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW061E | Regeneron Pharmaceuticals Inc./OS/Call [840]/GOLDS | - | - | 840,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,547 % | 0,443 | -0,008 | 3,512 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1J1M | Regeneron Pharmaceuticals Inc./OS/Call [840]/GOLDS | - | - | 840,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,227 % | 0,430 | -0,009 | 3,666 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K40 | Regeneron Pharmaceuticals Inc./OS/Call [840]/GOLDS | - | - | 840,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,857 % | 0,402 | -0,009 | 4,016 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K52 | Regeneron Pharmaceuticals Inc./OS/Call [840]/GOLDS | - | - | 840,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,446 % | 0,423 | -0,008 | 3,673 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K7A | Regeneron Pharmaceuticals Inc./OS/Call [840]/GOLDS | - | - | 840,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,538 % | 0,443 | -0,008 | 3,513 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1K8K | Regeneron Pharmaceuticals Inc./OS/Call [840]/GOLDS | - | - | 840,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,954 % | 0,358 | -0,010 | 4,715 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW3S5J | Regeneron Pharmaceuticals Inc./OS/Call [840]/GOLDS | - | - | 840,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,725 % | 0,459 | -0,008 | 3,323 | 17.03.2028 | 0,010 | Goldman Sachs | ||
| GW4QET | Regeneron Pharmaceuticals Inc./OS/Call [840]/GOLDS | - | - | 840,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,871 % | 0,483 | -0,008 | 3,078 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| JZ97UT | Regeneron Pharmaceuticals Inc./OS/Call [840]/JPMD | - | - | 840,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,419 % | 0,077 | -0,008 | 14,936 | 18.09.2026 | 0,010 | JP Morgan | ||
| JY3N4H | Regeneron Pharmaceuticals Inc./OS/Call [840]/JPMD | - | - | 840,000 | call | Regeneron Pharmaceuticals Inc. | - | 35,656 % | 0,219 | -0,009 | 7,926 | 15.01.2027 | 0,010 | JP Morgan | ||
| JY3YV4 | Regeneron Pharmaceuticals Inc./OS/Call [840]/JPMD | - | - | 840,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,074 % | 0,291 | -0,010 | 6,023 | 19.03.2027 | 0,010 | JP Morgan | ||
| JY5TYX | Regeneron Pharmaceuticals Inc./OS/Call [840]/JPMD | - | - | 840,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,203 % | 0,195 | -0,009 | 8,712 | 18.12.2026 | 0,010 | JP Morgan | ||
| PK33WH | | Regeneron Pharmaceuticals Inc./OS/Call [850]/BNP | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,036 % | 0,204 | -0,011 | 7,866 | 18.12.2026 | 0,010 | BNP Paribas | |
| PK33WE | | Regeneron Pharmaceuticals Inc./OS/Call [850]/BNP | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | - | 64,472 % | 0,194 | -0,026 | 8,017 | 18.09.2026 | 0,010 | BNP Paribas | |
| PK5ZKJ | | Regeneron Pharmaceuticals Inc./OS/Call [850]/BNP | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,922 % | 0,226 | -0,010 | 7,265 | 15.01.2027 | 0,010 | BNP Paribas | |
| GW1J1Y | Regeneron Pharmaceuticals Inc./OS/Call [850]/GOLDS | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,273 % | 0,421 | -0,009 | 3,695 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K41 | Regeneron Pharmaceuticals Inc./OS/Call [850]/GOLDS | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,875 % | 0,392 | -0,009 | 4,054 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K4K | Regeneron Pharmaceuticals Inc./OS/Call [850]/GOLDS | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,492 % | 0,434 | -0,008 | 3,544 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1K58 | Regeneron Pharmaceuticals Inc./OS/Call [850]/GOLDS | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,273 % | 0,421 | -0,009 | 3,695 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K8N | Regeneron Pharmaceuticals Inc./OS/Call [850]/GOLDS | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,406 % | 0,343 | -0,010 | 4,843 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW3S4C | Regeneron Pharmaceuticals Inc./OS/Call [850]/GOLDS | - | - | 850,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,355 % | 0,449 | -0,008 | 3,378 | 17.03.2028 | 0,010 | Goldman Sachs |